◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items
百花医药 — Financial Statements
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020
+Revenue 386.0M 369.0M 350.0M 281.0M 84.5M
Revenue Growth % 4.6% 5.4% 24.6% 232.4% --
Total Revenue 386.0M 369.0M 350.0M 281.0M 84.5M
Cost Of Revenue 188.0M 188.0M 210.0M 169.0M 221.0M
+Gross Profit 198.0M 181.0M 140.0M 112.0M -136.5M
Gross Margin % 51.3% 49.1% 40.0% 39.9% -161.4%
Total Operating Cost 354.0M 355.0M 383.0M 268.0M 468.0M
Selling Expenses 11.4M 13.1M 15.4M 7.9M 4.2M
Admin Expenses 60.0M 63.6M 65.8M 61.4M 62.8M
Rd Expenses 29.5M 31.9M 27.5M 5.3M 6.1M
Finance Expenses -1.4M -866,200 -275,800 -106,800 17.0M
+Operating Income 37.0M 18.0M -30.7M 63.5M -371.0M
Operating Margin % 9.6% 4.9% -8.8% 22.6% -438.9%
Non Operating Income 175,500 124,800 106,500 207,200 70.3M
Non Operating Expenses 346,600 1.6M 1.5M 1.6M 15.2M
Investment Income 3.5M 1.2M -766,000 -2.1M 1.9M
Fair Value Change Income -125,000 704,900 777,000 2.5M 5.5M
Asset Disposal Income 89,500 14,300 1,100 4,800 548,300
Asset Impairment Loss 43.5M 49.3M 57.4M 18.6M 149.0M
Other Income 1.4M 1.5M 2.3M 49.6M 4.8M
Income Before Tax 36.9M 16.5M -32.1M 62.2M -316.0M
Income Tax -4.6M 3.5M 2.6M 2.3M 4.1M
+Net Income 41.5M 13.0M -34.7M 59.9M -320.0M
Net Margin % 10.7% 3.5% -9.9% 21.3% -378.6%
Net Income Attributable 41.5M 13.0M -34.8M 59.8M -320.0M
Minority Interest -- -- 27,500 47,100 1,000
Eps Basic 0.11 0.03 -0.09 0.16 -0.82
Eps Diluted 0.11 0.03 -0.09 0.16 -0.82
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020
Cash And Equivalents 272.0M 202.0M 136.0M 86.9M 45.6M
Trading Financial Assets -- -- -- -- 10.0M
Accounts Receivable 81.0M 16.4M 19.4M 17.8M 22.1M
Notes Receivable 3.8M 400,000 6.8M 3.7M 3.9M
Notes And Accounts Receivable 84.8M 16.8M 26.2M 21.5M 25.9M
Prepayments 3.0M 5.0M 3.0M 2.4M 3.0M
Inventory 99.7M 125.0M 149.0M 194.0M 188.0M
Total Current Assets 583.0M 565.0M 506.0M 468.0M 440.0M
Long Term Equity Investment 59.9M 59.7M 56.6M 54.2M 57.2M
Fixed Assets -- 137.0M 145.0M 162.0M 182.0M
Fixed Assets Total 140.0M 137.0M 145.0M 162.0M 182.0M
Construction In Progress -- -- -- -- --
Construction In Progress Total -- -- -- -- --
Intangible Assets 8.4M 10.1M 11.5M 11.7M 12.5M
Long Term Deferred Expenses 2.7M 3.0M 4.0M 4.7M 3.8M
Total Non Current Assets 531.0M 497.0M 496.0M 514.0M 534.0M
Total Assets 1.1B 1.1B 1.0B 982.0M 975.0M
Short Term Borrowings -- -- -- 6.3M --
Accounts Payable 86.7M 101.0M 92.8M 58.4M 50.0M
Advance Receipts -- -- -- -- --
Contract Liabilities 141.0M 111.0M 98.9M 85.7M 94.8M
Total Current Liabilities 309.0M 308.0M 289.0M 254.0M 308.0M
Long Term Borrowings -- -- -- -- --
Total Non Current Liabilities 46.8M 47.0M 45.5M 42.2M 42.3M
Total Liabilities 356.0M 355.0M 335.0M 296.0M 351.0M
Paid In Capital 384.0M 382.0M 378.0M 375.0M 375.0M
Capital Reserve 2.3B 2.3B 2.2B 2.2B 2.2B
Surplus Reserve 5.0M 5.0M 5.0M 5.0M 5.0M
Retained Earnings -1.9B -1.9B -2.0B -1.9B -2.0B
Minority Equity -- -- -- 4.9M 4.9M
Equity Attributable 759.0M 707.0M 667.0M 681.0M 619.0M
Total Equity 759.0M 707.0M 667.0M 686.0M 624.0M
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020
Cash From Sales 391.0M 348.0M 311.0M 266.0M 143.0M
Tax Refunds Received -- -- 4.6M -- --
Total Operating Cash Inflow 398.0M 357.0M 335.0M 286.0M 238.0M
Cash Paid For Goods 127.0M 110.0M 109.0M 71.9M 60.3M
Cash Paid To Employees 154.0M 147.0M 139.0M 125.0M 134.0M
Taxes Paid 14.1M 11.8M 9.7M 8.4M 11.9M
Total Operating Cash Outflow 318.0M 295.0M 282.0M 251.0M 261.0M
Operating Cash Flow 80.3M 62.1M 53.2M 34.7M -23.3M
Total Investing Cash Inflow 537.0M 168.0M 64.8M 64.7M 80.4M
Total Investing Cash Outflow 559.0M 184.0M 75.3M 64.4M 46.8M
Investing Cash Flow -22.1M -15.7M -10.6M 297,300 33.6M
Cash From Borrowings -- -- -- 6.3M --
Dividends And Interest Paid -- -- 120,600 39,200 751,600
Debt Repayments -- -- 6.3M -- 20.0M
Total Financing Cash Inflow 11.8M 19.9M 12.6M 6.3M 4.9M
Total Financing Cash Outflow -- -- 6.4M 39,200 20.8M
Financing Cash Flow 11.8M 19.9M 6.2M 6.3M -15.9M
Net Change In Cash 70.0M 66.3M 48.8M 41.3M -5.5M
Ending Cash Balance 272.0M 202.0M 136.0M 86.9M 45.6M
Capex 24.6M 17.2M 2.4M 6.0M 3.8M
NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...